Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial

Jawad Fares(Neurological Surgery), Atique U. Ahmed(Neurological Surgery), Ilya V. Ulasov(Neurological Surgery), Adam M. Sonabend(Neurological Surgery), Jason Miska(Northwestern University), Catalina Lee-Chang(Northwestern University), Irina V. Balyasnikova(Neurological Surgery), James P. Chandler(Neurological Surgery), Jana Portnow(City of Hope), Matthew C. Tate(Neurological Surgery), Priya Kumthekar(Northwestern University), Rimas V. Lukas(Northwestern University), Sean Grimm(Northwestern University), Ann K. Adams(Northwestern University), Charles Hébert(Southern Research Institute), Theresa V. Strong(Foundation for Prader-Willi Research), Christina Amidei(Northwestern University), Víctor A. Arrieta(Neurological Surgery), Μαρκέλλα Ζαννίκου(Neurological Surgery), Craig Horbinski(Northwestern University), Hui Zhang(Northwestern University), Kirsten B. Burdett(Northwestern University), David T. Curiel(Washington University in St. Louis), Sean Sachdev(Northwestern University), Karen S. Aboody(City of Hope), Roger Stupp(Northwestern University), Maciej S. Lesniak(Northwestern University)
The Lancet Oncology
June 29, 2021
Cited by 205Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis